Subtotal tumor resection as a predictor of post-resection hydrocephalus in pediatric patients with posterior fossa tumors

肿瘤次全切除术作为儿童后颅窝肿瘤患者术后脑积水的预测因素

阅读:1

Abstract

OBJECTIVE: Pediatric posterior fossa tumor (PFT) resection is frequently complicated by postoperative hydrocephalus. Previous hydrocephalus risk stratification tools demonstrate limited performance in external validation and do not account for important intra- and post-operative variables. We aimed to evaluate additional risk factors for post-resection hydrocephalus to improve risk-stratification. METHODS: We conducted a retrospective analysis of pediatric patients who underwent resection of primary PFT's at our institution (January 2016-June 2024). We collected perioperative variables thought to influence hydrocephalus risk. The primary outcome was permanent CSF diversion within 6 months after resection. We used univariable and multivariable logistic regression with bidirectional stepwise selection to identify predictors of post-resection hydrocephalus. RESULTS: A total of 112 patients were included. We identified age < 5 years, moderate/severe hydrocephalus, and subtotal resection (STR; ≥ 1.5 cm(2) residual tumor) as independent predictors of post-resection hydrocephalus on multivariable regression. STR exhibited an odds ratio of 8.25 (95% CI 2.72-26.84; p < 0.001), highlighting its strong association with the need for permanent CSF diversion. A scoring tool that incorporated STR and an age cutoff of < 5 years improved the discriminative performance (area under the ROC curve = 0.826) compared to the modified Canadian Preoperative Prediction Rule for Hydrocephalus (AUC = 0.720). CONCLUSIONS: These findings suggest STR is associated with increased risk of persistent hydrocephalus and emphasize careful intraoperative decision-making when pursuing incomplete resection. Future multicenter studies will be necessary to validate this framework and to further elucidate how STR, in conjunction with age and hydrocephalus severity, can be leveraged to optimize treatment strategies in diverse healthcare settings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。